PL2212324T3 - Związki posiadające właściwości przeciwwirusowe - Google Patents
Związki posiadające właściwości przeciwwirusoweInfo
- Publication number
- PL2212324T3 PL2212324T3 PL09771849T PL09771849T PL2212324T3 PL 2212324 T3 PL2212324 T3 PL 2212324T3 PL 09771849 T PL09771849 T PL 09771849T PL 09771849 T PL09771849 T PL 09771849T PL 2212324 T3 PL2212324 T3 PL 2212324T3
- Authority
- PL
- Poland
- Prior art keywords
- compounds
- antiviral properties
- antiviral
- properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2008903407A AU2008903407A0 (en) | 2008-07-02 | Compounds having antiviral properties | |
| US16193109P | 2009-03-20 | 2009-03-20 | |
| PCT/AU2009/000858 WO2010000032A1 (en) | 2008-07-02 | 2009-07-02 | Compounds having antiviral properties |
| EP09771849.8A EP2212324B1 (en) | 2008-07-02 | 2009-07-02 | Compounds having antiviral properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2212324T3 true PL2212324T3 (pl) | 2014-11-28 |
Family
ID=41465417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09771849T PL2212324T3 (pl) | 2008-07-02 | 2009-07-02 | Związki posiadające właściwości przeciwwirusowe |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8318732B2 (pl) |
| EP (2) | EP2759544A1 (pl) |
| JP (1) | JP5535204B2 (pl) |
| CN (1) | CN102143962B (pl) |
| AU (1) | AU2009266421B2 (pl) |
| BR (1) | BRPI0913934A2 (pl) |
| CA (1) | CA2729663A1 (pl) |
| ES (1) | ES2459046T3 (pl) |
| IL (1) | IL210207A0 (pl) |
| MX (1) | MX2011000149A (pl) |
| NZ (1) | NZ590126A (pl) |
| PL (1) | PL2212324T3 (pl) |
| SG (1) | SG192452A1 (pl) |
| WO (1) | WO2010000032A1 (pl) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5539978B2 (ja) * | 2008-07-02 | 2014-07-02 | アベキサ・リミテッド | チアゾピリミジノンおよびその使用 |
| FR2947272B1 (fr) * | 2009-06-29 | 2014-09-26 | Univ Paris Curie | Utilisation d'arn interferents pour le traitement d'une infection par le vih |
| WO2011105590A1 (ja) * | 2010-02-26 | 2011-09-01 | 日本たばこ産業株式会社 | １，３，４，８－テトラヒドロ－２Ｈ－ピリド［１，２－ａ］ピラジン誘導体及びそのＨＩＶインテグラーゼ阻害剤としての利用 |
| US8846659B2 (en) * | 2010-12-10 | 2014-09-30 | Bristol-Myers Squibb Company | HIV integrase inhibitors |
| WO2015105657A1 (en) * | 2013-12-19 | 2015-07-16 | Ptc Therapeutics, Inc. | Methods for modulating the amount of rna transcripts |
| DK3138840T3 (da) * | 2014-04-28 | 2020-12-21 | Jiangsu Kanion Pharmaceutical Co Ltd | Thiadiazolidin-derivat som anti-enterovirus 71 |
| EP4249472A3 (en) | 2015-05-30 | 2023-12-13 | PTC Therapeutics, Inc. | Methods for modulating rna splicing |
| US10874672B2 (en) | 2015-12-10 | 2020-12-29 | Ptc Therapeutics, Inc. | Methods for treating Huntington's disease |
| US20180096362A1 (en) * | 2016-10-03 | 2018-04-05 | Amy Ashley Kwan | E-Commerce Marketplace and Platform for Facilitating Cross-Border Real Estate Transactions and Attendant Services |
| CA3043755A1 (en) | 2016-11-28 | 2018-05-31 | Ptc Therapeutics, Inc. | Methods for modulating rna splicing |
| KR20200033249A (ko) | 2017-06-05 | 2020-03-27 | 피티씨 테라퓨틱스, 인크. | 헌팅턴병 치료 화합물 |
| JP2020523365A (ja) | 2017-06-14 | 2020-08-06 | ピーティーシー セラピューティクス，インコーポレーテッド | Ｒｎａスプライシングを改変する方法 |
| CA3067592A1 (en) | 2017-06-28 | 2019-01-03 | Ptc Therapeutics, Inc. | Methods for treating huntington's disease |
| CN111182898B (zh) | 2017-06-28 | 2024-04-16 | Ptc医疗公司 | 用于治疗亨廷顿氏病的方法 |
| CA3094703A1 (en) | 2018-03-27 | 2019-10-03 | Ptc Therapeutics, Inc. | Compounds for treating huntington's disease |
| WO2020005882A1 (en) | 2018-06-27 | 2020-01-02 | Ptc Therapeutics, Inc. | Heteroaryl compounds for treating huntington's disease |
| KR20210038845A (ko) | 2018-06-27 | 2021-04-08 | 피티씨 테라퓨틱스, 인크. | 헌팅턴병 치료를 위한 헤테로아릴 화합물 |
| SG11202012674PA (en) | 2018-06-27 | 2021-01-28 | Ptc Therapeutics Inc | Heterocyclic and heteroaryl compounds for treating huntington's disease |
| CN119039288A (zh) * | 2019-06-19 | 2024-11-29 | Viiv保健英国第五有限公司 | 作为人类免疫缺陷病毒复制抑制剂的吡啶并[2,3-d]嘧啶衍生物 |
| WO2021111124A1 (en) | 2019-12-02 | 2021-06-10 | Storm Therapeutics Limited | Polyheterocyclic compounds as mettl3 inhibitors |
| CN114751902B (zh) * | 2021-01-08 | 2024-11-22 | 正大天晴药业集团股份有限公司 | 一种4H-吡啶并[1,2-a]嘧啶-4-酮化合物的制备方法 |
| WO2024260929A1 (en) * | 2023-06-19 | 2024-12-26 | F. Hoffmann-La Roche Ag | Trem2 agonists |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101513402B (zh) | 2001-08-10 | 2012-03-21 | 盐野义制药株式会社 | 抗病毒药 |
| TW200526635A (en) * | 2003-12-22 | 2005-08-16 | Shionogi & Co | Hydroxypyrimidinone derivative having HIV integrase inhibitory activity |
| US7273859B2 (en) * | 2004-05-12 | 2007-09-25 | Bristol-Myers Squibb Company | HIV integrase inhibitors: cyclic pyrimidinone compounds |
| JP5094725B2 (ja) * | 2005-10-04 | 2012-12-12 | イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ | Ｈｉｖインテグラーゼ阻害剤 |
| JP2008019644A (ja) | 2006-07-13 | 2008-01-31 | Hitoshi Koide | 石油または天然ガスの増進回収方法及びその増進回収システム |
| BRPI0722411A2 (pt) * | 2006-12-22 | 2012-06-05 | Avexa Ltd | pirimidinonas bicìclicas e seus usos |
| CA2729656A1 (en) | 2008-07-02 | 2010-01-07 | Avexa Limited | Imidazopyrimidinones and uses thereof |
-
2009
- 2009-07-02 EP EP14161042.8A patent/EP2759544A1/en not_active Withdrawn
- 2009-07-02 MX MX2011000149A patent/MX2011000149A/es active IP Right Grant
- 2009-07-02 CA CA2729663A patent/CA2729663A1/en not_active Abandoned
- 2009-07-02 CN CN200980134068.6A patent/CN102143962B/zh not_active Expired - Fee Related
- 2009-07-02 WO PCT/AU2009/000858 patent/WO2010000032A1/en active Application Filing
- 2009-07-02 ES ES09771849.8T patent/ES2459046T3/es active Active
- 2009-07-02 BR BRPI0913934A patent/BRPI0913934A2/pt not_active IP Right Cessation
- 2009-07-02 EP EP09771849.8A patent/EP2212324B1/en not_active Not-in-force
- 2009-07-02 PL PL09771849T patent/PL2212324T3/pl unknown
- 2009-07-02 NZ NZ590126A patent/NZ590126A/xx not_active IP Right Cessation
- 2009-07-02 US US12/734,036 patent/US8318732B2/en not_active Expired - Fee Related
- 2009-07-02 JP JP2011515028A patent/JP5535204B2/ja not_active Expired - Fee Related
- 2009-07-02 SG SG2013050398A patent/SG192452A1/en unknown
- 2009-07-02 AU AU2009266421A patent/AU2009266421B2/en not_active Ceased
-
2010
- 2010-12-23 IL IL210207A patent/IL210207A0/en unknown
-
2012
- 2012-09-13 US US13/614,049 patent/US8563562B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8563562B2 (en) | 2013-10-22 |
| AU2009266421A1 (en) | 2010-01-07 |
| US20110039842A1 (en) | 2011-02-17 |
| BRPI0913934A2 (pt) | 2015-10-20 |
| US20130059865A1 (en) | 2013-03-07 |
| CN102143962A (zh) | 2011-08-03 |
| AU2009266421B2 (en) | 2013-07-11 |
| CN102143962B (zh) | 2015-03-11 |
| CA2729663A1 (en) | 2010-01-07 |
| EP2212324A4 (en) | 2011-01-19 |
| EP2212324B1 (en) | 2014-03-26 |
| US8318732B2 (en) | 2012-11-27 |
| EP2759544A1 (en) | 2014-07-30 |
| JP5535204B2 (ja) | 2014-07-02 |
| ES2459046T3 (es) | 2014-05-07 |
| SG192452A1 (en) | 2013-08-30 |
| JP2011526248A (ja) | 2011-10-06 |
| MX2011000149A (es) | 2011-02-24 |
| EP2212324A1 (en) | 2010-08-04 |
| WO2010000032A1 (en) | 2010-01-07 |
| NZ590126A (en) | 2012-11-30 |
| IL210207A0 (en) | 2011-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL210207A0 (en) | Compounds having antiviral properties | |
| IL246547A0 (en) | Antiviral compounds | |
| ZA201000614B (en) | Antiviral compounds | |
| GB0800035D0 (en) | Compounds | |
| ZA201103943B (en) | Purine compounds | |
| EP2234623A4 (en) | ANTIVIRAL CONNECTIONS | |
| GB0804702D0 (en) | Compounds | |
| GB0800367D0 (en) | Compounds | |
| GB0801220D0 (en) | Compounds | |
| GB0801265D0 (en) | Compounds | |
| IL192335A0 (en) | Antiviral compounds | |
| GB0819528D0 (en) | Antiviral compounds | |
| GB0816600D0 (en) | Antiviral compounds | |
| AU2008903407A0 (en) | Compounds having antiviral properties | |
| ZA201000662B (en) | Antiviral compounds | |
| GB0804064D0 (en) | Compounds | |
| GB0800841D0 (en) | Compounds | |
| GB0803495D0 (en) | Compounds | |
| GB0802587D0 (en) | Compounds | |
| GB0802586D0 (en) | Compounds | |
| GB0802231D0 (en) | Compounds | |
| GB0802192D0 (en) | Compounds | |
| GB0802191D0 (en) | Compounds | |
| GB0801596D0 (en) | Compounds | |
| GB0805048D0 (en) | Niovel compounds |